— Know what they know.
Not Investment Advice

LDR NYSE

Landauer Inc.
1W: -0.5% 1M: -0.9% 3M: +22.1% 1Y: +50.7% 3Y: +102.8% 5Y: +16.8%
$67.20
Last traded 2017-10-18 — delisted
NYSE · Healthcare · Medical - Equipment & Services

Cash Flow Trends

Operating Cash Flow
$32M +11.6% ▲
5Y CAGR: +0.2%
Capital Expenditures
$9M -11.5% ▼
5Y CAGR: -7.2%
Free Cash Flow
$23M +11.7% ▲
5Y CAGR: +4.3%
Dividends Paid
$0 +0.0% ▲
Buybacks
$13M +13.2% ▲
Net Change in Cash
-$2M -123.7% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2012FY2013FY2014FY2015FY2016
— Operating Activities —
Net Income$19M$5M-$25M$15M$18M
Depreciation & Amort.$12M$15M$14M$12M$11M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$30M$3M-$16M$14M-$2M
Other Non-Cash Items-$25M-$6M$35M-$14M$11M
Operating Cash Flow$36M$26M$37M$28M$32M
— Investing Activities —
Capital Expenditures-$15M-$9M-$4M-$8M-$9M
Acquisitions (Net)-$110M$0-$2M$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$880K-$2M-$1M$6M$11M
Investing Cash Flow-$126M-$11M-$7M-$2M$2M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased-$18M-$11M-$7M-$15M-$13M
Dividends Paid$0$0$0$0$0
Other Financing$101M-$21M-$31M-$17M-$35M
Financing Cash Flow$101M-$21M-$31M-$17M-$35M
Net Change in Cash$10M-$6M-$2M$9M-$2M
Cash End of Period$18M$11M$7M$15M$13M
Free Cash Flow$20M$17M$33M$20M$23M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms